Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting

Virology

Volumn 397, Issue 2, 2010, Pages 299-310

  Gross, Henrik ^a   Barth, Stephanie ^a   Palermo, Richard D ^b   Mamiani, Alfredo ^a   Hennard, Christine ^c   Zimber Strobl, Ursula ^c   West, Michelle J ^b   Kremmer, Elisabeth ^c   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

aDMA; Arginine; DNA binding; EBNA2; EBV; Epstein Barr virus; Methylation; Nuclear antigen 2; RBPJ ; sDMA

Indexed keywords

ARGININE; CITRULLINE; EPSTEIN BARR VIRUS ANTIGEN 2; GLYCINE; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; ASYMMETRIC SYNTHESIS; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA METHYLATION; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; ARGININE; CELL LINE; DNA; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; METHYLATION; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 75949101284     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.023     Document Type: Article

References (52)

1. Azzouz T.N., Pillai R.S., Dapp C., Chari A., Meister G., Kambach C., Fischer U., and Schumperli D. Toward an assembly line for U7 snRNPs: interactions of U7-specific Lsm proteins with PRMT5 and SMN complexes. J. Biol. Chem. 280 41 (2005) 34435-34440 Electronic publication 2005 Aug 8
2. Bark-Jones S.J., Webb H.M., and West M.J. EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. Oncogene 25 12 (2006) 1775-1785
3. Barth S., Liss M., Voss M.D., Dobner T., Fischer U., Meister G., and Grässer F.A. Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein. J. Virol. 77 8 (2003) 5008-5013
4. Barth S., Pfuhl T., Mamiani A., Ehses C., Roemer K., Kremmer E., Jaker C., Hock J., Meister G., and Grässer F.A. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 36 2 (2008) 666-675
5. Bedford M.T., and Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33 1 (2009) 1-13
6. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18 3 (2005) 263-272
7. Bornkamm G.W., and Hammerschmidt W. Molecular virology of Epstein-Barr virus. Philos. Trans. R Soc. Lond. B Biol. Sci. 356 1408 (2001) 437-459
8. Chang B., Chen Y., Zhao Y., and Bruick R.K. JMJD6 is a histone arginine demethylase. Science 318 5849 (2007) 444-447
9. Cohen J.I., Wang F., and Kieff E. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65 5 (1991) 2545-2554
10. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A.J., and Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118 5 (2004) 545-553
11. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 5 (1983) 1475-1489
12. Friesen W.J., and Dreyfuss G. Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J. Biol. Chem. 275 34 (2000) 26370-26375
13. Gary J.D., and Clarke S. RNA and protein interactions modulated by protein arginine methylation. Prog. Nucleic Acid Res. Mol. Biol. 61 (1998) 65-131
14. Grässer F.A., Haiss P., Göttel S., and Mueller Lantzsch N. Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J. Virol. 65 7 (1991) 3779-3788
15. Grässer F.A., Göttel S., Haiss P., Boldyreff B., Issinger O.G., and Mueller Lantzsch N. Phosphorylation of the Epstein-Barr virus nuclear antigen 2. Biochem. Biophys. Res. Commun. 186 3 (1992) 1694-1701
16. Grässer F.A., Sauder C., Haiss P., Hille A., König S., Göttel S., Kremmer E., Leinenbach H.P., Zeppezauer M., and Mueller Lantzsch N. Immunological detection of proteins associated with the Epstein-Barr virus nuclear antigen 2A. Virology 195 2 (1993) 550-560
17. Grundhoff A.T., Kremmer E., Tureci O., Glieden A., Gindorf C., Atz J., Mueller Lantzsch N., Schubach W.H., and Grässer F.A. Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C. J. Biol. Chem. 274 27 (1999) 19136-19144
18. Harada S., Yalamanchili R., and Kieff E. Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association. J. Virol. 75 5 (2001) 2482-2487
19. Henkel T., Ling P.D., Hayward S.D., and Peterson M.G. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265 5168 (1994) 92-95
20. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 5532 (2001) 1074-1080
21. Kim S., Merrill B.M., Rajpurohit R., Kumar A., Stone K.L., Papov V.V., Schneiders J.M., Szer W., Wilson S.H., Paik W.K., and Williams K.R. Identification of N(G)-methylarginine residues in human heterogeneous RNP protein A1: Phe/Gly-Gly-Gly-Arg-Gly-Gly-Gly/Phe is a preferred recognition motif. Biochemistry 36 17 (1997) 5185-5192
22. Kremmer E., Kranz B., Hille A., Klein K., Eulitz M., Hoffmann-Fezer G., Feiden W., Herrmann K., Delecluse H.-J., Delsol G., Bornkamm G.W., Mueller-Lantzsch N., and Grässer F.A. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 208 (1995) 336-342
23. Lee D.Y., Teyssier C., Strahl B.D., and Stallcup M.R. Role of protein methylation in regulation of transcription. Endocr. Rev. 26 2 (2005) 147-170 Electronic publication 2004 Oct 12
24. Ling P.D., and Hayward S.D. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J. Virol. 69 3 (1995) 1944-1950
25. Maier S., Santak M., Mantik A., Grabusic K., Kremmer E., Hammerschmidt W., and Kempkes B. A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent. J. Virol. 79 14 (2005) 8784-8792
26. Mann K.P., Staunton D., and Thorley Lawson D.A. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55 3 (1985) 710-720
27. Meitinger C., Strobl L.J., Marschall G., Bornkamm G.W., and Zimber-Strobl U. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element. J. Virol. 68 11 (1994) 7497-7506
28. Mowen K.A., Tang J., Zhu W., Schurter B.T., Shuai K., Herschman H.R., and David M. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104 5 (2001) 731-741
29. Paik W.K., and Kim S. Enzymatic methylation of protein fractions from calf thymus nuclei. Biochem. Biophys. Res. Commun. 29 1 (1967) 14-20
30. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., and Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell Biol. 24 21 (2004) 9630-9645
31. Palermo R.D., Webb H.M., Gunnell A., and West M.J. Regulation of transcription by the Epstein-Barr virus nuclear antigen EBNA 2. Biochem. Soc. Trans. 36 Pt. 4 (2008) 625-628
32. Petti L., Sample C., and Kieff E. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176 2 (1990) 563-574
33. Richard S., Morel M., and Cleroux P. Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5). Biochem. J. 388 Pt. 1 (2005) 379-386
34. Rickinson, A. B., Kieff, E.,2007. Epstein-Barr virus, In: Knipe, D. M., Howley, P. M., (Eds.), Fields Virology, Vol. 2. Lippincott-Raven, Philadelphia, pp. 2655-2700.
35. Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., and Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. U. S. A. 88 14 (1991) 6343-6347
36. Sauder C., Haiss P., Grässer F.A., Zimber Strobl U., and Mueller Lantzsch N. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. J. Gen. Virol. 75 Pt. 11 (1994) 3067-3079
37. Sauder C., Gotzinger N., Schubach W.H., Horvath G.C., Kremmer E., Krebs A., König S., Zimber Strobl U., Mueller Lantzsch N., and Grässer F.A. Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies. J. Gen. Virol. 77 Pt. 5 (1996) 991-996
38. Stallcup M.R., Kim J.H., Teyssier C., Lee Y.H., Ma H., and Chen D. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. J. Steroid Biochem. Mol. Biol. 85 2-5 (2003) 139-145
39. Tong X., Yalamanchili R., Harada S., and Kieff E. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. J. Virol. 68 10 (1994) 6188-6197
40. Tsui S., and Schubach W.H. Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. J. Virol. 68 7 (1994) 4287-4294
41. Voss M.D., Hille A., Barth S., Spurk A., Hennrich F., Holzer D., Mueller-Lantzsch N., Kremmer E., and Grässer F.A. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. J. Virol. 75 23 (2001) 11781-11790
42. Waltzer L., Logeat F., Brou C., Israel A., Sergeant A., and Manet E. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. 13 23 (1994) 5633-5638
43. Waltzer L., Perricaudet M., Sergeant A., and Manet E. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J. Virol. 70 9 (1996) 5909-5915
44. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S., Stallcup M.R., Allis C.D., and Coonrod S.A. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306 5694 (2004) 279-283
45. Wu D.Y., Kalpana G.V., Goff S.P., and Schubach W.H. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J. Virol. 70 9 (1996) 6020-6028
46. Wu D.Y., Krumm A., and Schubach W.H. Promotor-specific targeting of human SWi-SNF complex by Epstein-Barr virus nuclear protein 2. J. Virol. 74 19 (2000) 8893-8903
47. Young L.S., Lau R., Rowe M., Niedobitek G., Packham G., Shanahan F., Rowe D.T., Greenspan D., Greenspan J.S., Rickinson A.B., et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65 6 (1991) 2868-2874
48. Yue W., Davenport M.G., Shackelford J., and Pagano J.S. Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function. J. Virol. 78 7 (2004) 3542-3552
49. Yue W., Gershburg E., and Pagano J.S. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. J. Virol. 79 9 (2005) 5880-5885
50. Yue W., Shackelford J., and Pagano J.S. cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis. J. Virol. 80 4 (2006) 2045-2050
51. Zimber Strobl U., and Strobl L.J. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin. Cancer Biol. 11 6 (2001) 423-434
52. Zimber Strobl U., Kremmer E., Grässer F., Marschall G., Laux G., and Bornkamm G.W. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12 1 (1993) 167-175